Coronavac approved for emergency use in 18-59 age group in SA

The CoronaVac Covid-19 vaccine has been approved for emergency use access by the South African Health Products Regulatory Authority (Sahpra).

The inactivated vaccine — which has already been administered to over 2.5 billion people worldwide — was approved for use in the age group 18-59.

Manufactured by a biopharmaceutical company based in China, Sinovac Biotech, the vaccine will be distributed by their in-country South African partner, the Numolux Group.